Browsing by Author Hüsing, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
8-Apr-2016A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort.Terry, KL; Schock, H; Fortner, RT; Hüsing, A; Fichorova, RN, et al
28-Feb-2017Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.Hüsing, A; Fortner, RT; Kühn, T; Overvad, K; Tjønneland, A, et al
20-Mar-2017Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.Fortner, RT; Vitonis, AF; Schock, H; Hüsing, A; Johnson, T, et al
4-Jan-2021Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score.Aleksandrova, K; Reichmann, R; Kaaks, R; Jenab, M; Bueno-de-Mesquita, HB, et al
11-Dec-2017Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: results from the EPIC cohortFortner, RT; Schock, H; Le Cornet, C; Hüsing, A; Vitonis, AF, et al
21-Aug-2019Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective studyKühn, T; Stepien, M; López-Nogueroles, M; Machado, AD; Sookthai, D, et al
3-Dec-2018Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohortsLi, K; Anderson, G; Viallon, V; Arveux, P; Kvaskoff, M, et al
1-Feb-2018Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.Kaaks, R; Fortner, RT; Hüsing, A; Barrdahl, M; Hopper, M, et al